Investor Alert

New York Markets Open in:

Denali Therapeutics Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 24, 2023, 7:03 p.m.





+0.10 +0.44%


Volume 44,736

Quotes are delayed by 20 min


Previous close

$ 22.91

$ 22.90


-0.01 -0.04%

Day low

Day high




52 week low

52 week high




Jennifer E. Cook

Jennifer E. Cook is on the board of Jazz Pharmaceuticals Plc and 5 other companies. Ms. Cook previously held the position of Chief Executive Officer & Director at GRAIL LLC, Senior Vice President-Immunology & Ophthalmology at Genentech, Inc., Senior VP & Global Head-Clinical Operations at Roche Pharmaceuticals, Inc. and Principal at Prizm Pharmaceuticals, Inc.

Jennifer E. Cook received a graduate degree and an undergraduate degree from Stanford University and an MBA from Haas School of Business.


Date Shares Transaction Value
06/02/2022 5,986   Award at $0 per share. 0
06/02/2021 2,074   Award at $0 per share. 0
06/01/2021 3,253   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Secretary, Chief Operating & Financial Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Mr. Steve E. Krognes
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Mr. Erik C. Harris
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Link to MarketWatch's Slice.